Seelos Therapeutics
SEEL
#10724
Rank
NZ$0.36 M
Marketcap
NZ$0.63
Share price
-31.49%
Change (1 day)
-98.06%
Change (1 year)

Earnings for Seelos Therapeutics (SEEL)

Earnings in 2024 (TTM): NZ$7.41 Million

According to Seelos Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$64.5 Million, an increase over its 2022 earnings that were of -NZ$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seelos Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$7.41 M-111.5%
2023 -NZ$64.5 Million-48.58%
2022 -NZ$0.13 Billion14.07%
2021 -NZ$0.11 Billion240.34%
2020 -NZ$32.31 Million-62.76%
2019 -NZ$86.76 Million587.73%
2018 -NZ$12.62 Million-36.54%
2017 -NZ$19.88 Million74.83%
2016 -NZ$11.37 Million-63.26%
2015 -NZ$30.95 Million-18.06%
2014 -NZ$37.77 Million46.19%
2013 -NZ$25.84 Million-31.67%
2012 -NZ$37.81 Million
2010 -NZ$35.42 Million448.63%
2009 -NZ$6.46 Million-25.83%
2008 -NZ$8.71 Million-45.65%
2007 -NZ$16.02 Million2.82%
2006 -NZ$15.58 Million-41.86%
2005 -NZ$26.79 Million-9.27%
2004 -NZ$29.53 Million114.92%
2003 -NZ$13.74 Million-70.78%
2002 -NZ$47.02 Million60.2%
2001 -NZ$29.35 Million70.3%
2000 -NZ$17.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.26 Billion-3,626.04%๐Ÿ‡บ๐Ÿ‡ธ USA